Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-16 4:30 pm Sale | 2023-10-04 | 13D | Standard BioTools Inc. LAB | VIKING GLOBAL INVESTORS LP | 8,289,116 9.500% | -34,705 (-0.42%) | Filing History |
| 2023-07-07 1:27 pm Sale | 2023-06-30 | 13G | Standard BioTools Inc. LAB | PRIMECAP MANAGEMENT CO/CA/ | 3,220,917 4.110% | -1,395,756 (-30.23%) | Filing History |
| 2023-07-03 5:17 pm Sale | 2023-07-03 | 13D | Standard BioTools Inc. LAB | Caligan Partners LP | 7,797,454 9.900% | -779,345 (-9.09%) | Filing History |
| 2023-02-14 4:33 pm Sale | 2022-12-31 | 13G | Standard BioTools Inc. LAB | North Sound Trading LP | 2,396,400 3.000% | -1,978,600 (-45.23%) | Filing History |
| 2023-02-14 1:18 pm Purchase | 2022-12-31 | 13G | Standard BioTools Inc. LAB | VIKING GLOBAL INVESTORS LP | 8,323,821 9.500% | 220,294 (+2.72%) | Filing History |
| 2023-02-14 10:26 am Purchase | 2022-12-31 | 13G | Standard BioTools Inc. LAB | Indaba Capital Management L.P. | 7,894,751 9.900% | 308,846 (+4.07%) | Filing History |
| 2023-02-09 4:02 pm Sale | 2022-12-31 | 13G | Standard BioTools Inc. LAB | PRIMECAP MANAGEMENT CO/CA/ | 4,616,673 5.820% | -476,730 (-9.36%) | Filing History |
| 2023-02-09 11:32 am Purchase | 2022-12-30 | 13G | Standard BioTools Inc. LAB | The Vanguard Group | 3,955,968 4.990% | 88,297 (+2.28%) | Filing History |
| 2022-12-30 5:10 pm Sale | 2022-12-29 | 13D | Standard BioTools Inc. LAB | Caligan Partners LP | 8,576,799 10.800% | -2,868,037 (-25.06%) | Filing History |
| 2022-11-14 4:43 pm Unchanged | 2022-11-14 | 13G | Standard BioTools Inc. LAB | RA Capital Management, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-08-05 11:13 am Purchase | 2022-08-04 | 13D | Standard BioTools Inc. LAB | Caligan Partners LP | 11,444,836 14.800% | 1,021,648 (+9.80%) | Filing History |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | Standard BioTools Inc. LAB | BlackRock Inc. BLK | 2,017,210 2.600% | -4,234,020 (-67.73%) | Filing History |
| 2022-06-07 10:31 am Purchase | 2022-06-03 | 13D | Standard BioTools Inc. LAB | Caligan Partners LP | 10,423,188 13.500% | 938,350 (+9.89%) | Filing History |
| 2022-05-03 12:40 pm Purchase | 2022-04-29 | 13D | Standard BioTools Inc. LAB | Caligan Partners LP | 9,484,838 12.300% | 1,104,573 (+13.18%) | Filing History |
| 2022-04-14 5:09 pm Purchase | 2022-04-04 | 13G | Standard BioTools Inc. LAB | VIKING GLOBAL INVESTORS LP | 8,103,527 9.500% | 8,103,527 (New Position) | Filing History |
| 2022-04-08 5:07 pm Purchase | 2022-04-04 | 13D | Standard BioTools Inc. LAB | Casdin Capital LLC | 37,582,346 32.740% | 37,582,346 (New Position) | Filing History |
| 2022-03-29 5:14 pm Unchanged | 2022-03-29 | 13D | Standard BioTools Inc. LAB | Caligan Partners LP | 8,380,265 10.900% | 0 (Unchanged) | Filing History |
| 2022-03-24 4:30 pm Purchase | 2022-03-14 | 13G | Standard BioTools Inc. LAB | RA Capital Management, L.P. | 4,651,177 6.000% | 4,651,177 (New Position) | Filing History |
| 2022-03-07 4:15 pm Purchase | 2022-02-24 | 13G | Standard BioTools Inc. LAB | North Sound Trading LP | 4,375,000 5.700% | 4,375,000 (New Position) | Filing History |
| 2022-02-14 3:46 pm Purchase | 2021-12-31 | 13G | Standard BioTools Inc. LAB | Indaba Capital Management L.P. | 7,585,905 9.900% | 49,555 (+0.66%) | Filing History |